USA - NASDAQ:SSII - US05453U2033 - Common Stock
The current stock price of SSII is 6.82 USD. In the past month the price decreased by -24.61%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.74 | 223.58B | ||
| ISRG | INTUITIVE SURGICAL INC | 66.16 | 204.22B | ||
| BSX | BOSTON SCIENTIFIC CORP | 35.53 | 155.32B | ||
| SYK | STRYKER CORP | 28.4 | 143.00B | ||
| IDXX | IDEXX LABORATORIES INC | 56.3 | 56.80B | ||
| BDX | BECTON DICKINSON AND CO | 13.5 | 55.79B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.68 | 50.82B | ||
| RMD | RESMED INC | 25.52 | 36.87B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.33 | 34.21B | ||
| PODD | INSULET CORP | 73.15 | 23.53B | ||
| DXCM | DEXCOM INC | 32.28 | 23.55B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.17 | 17.90B |
SS Innovations International, Inc. is a medical robotics company, which develops a fully autonomous medical robotic system using proprietary software. The company is headquartered in Fort Lauderdale, Florida and currently employs 378 full-time employees. The company went IPO on 2018-07-09. The Company’s product range includes its proprietary SSi Mantra surgical robotic system and its comprehensive suite of SSi Mudra surgical instruments, which support a variety of surgical procedures including robotic cardiac surgery. The SSi Mantra Surgical Robotic System is designed to enable surgeons to perform a wide range of surgical procedures including cardiovascular, thoracic, head and neck, gynecological, urological, cancer and general surgeries. The SSi Mantra 3 is comprised of components, such as Surgeon Console, Patient-Side Robotic Arm Carts, and Vision Cart. Its instruments under development include NADI-Automated Coronary Anastomotic Connector, SSi Multi-Fire Clip Applier, SSi Ultrasonic Surgical Device, SSi Maya-XR Pre-Operative Simulator, SSi Holographic Anatomy, SSi Yog-Tele Proctor, SSi Chitrasa-Advanced DICOM Viewer and SSi Mixed Reality Headset.
SS INNOVATIONS INTERNATIONAL
1600 Se 15Th Street, #512
FORT LAUDERDALE FLORIDA US
Employees: 378
Phone: 19544781410
SS Innovations International, Inc. is a medical robotics company, which develops a fully autonomous medical robotic system using proprietary software. The company is headquartered in Fort Lauderdale, Florida and currently employs 378 full-time employees. The company went IPO on 2018-07-09. The Company’s product range includes its proprietary SSi Mantra surgical robotic system and its comprehensive suite of SSi Mudra surgical instruments, which support a variety of surgical procedures including robotic cardiac surgery. The SSi Mantra Surgical Robotic System is designed to enable surgeons to perform a wide range of surgical procedures including cardiovascular, thoracic, head and neck, gynecological, urological, cancer and general surgeries. The SSi Mantra 3 is comprised of components, such as Surgeon Console, Patient-Side Robotic Arm Carts, and Vision Cart. Its instruments under development include NADI-Automated Coronary Anastomotic Connector, SSi Multi-Fire Clip Applier, SSi Ultrasonic Surgical Device, SSi Maya-XR Pre-Operative Simulator, SSi Holographic Anatomy, SSi Yog-Tele Proctor, SSi Chitrasa-Advanced DICOM Viewer and SSi Mixed Reality Headset.
The current stock price of SSII is 6.82 USD. The price increased by 0.74% in the last trading session.
SSII does not pay a dividend.
SSII has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on SSII.
SS INNOVATIONS INTERNATIONAL (SSII) currently has 378 employees.
SS INNOVATIONS INTERNATIONAL (SSII) has a market capitalization of 1.32B USD. This makes SSII a Small Cap stock.
ChartMill assigns a technical rating of 1 / 10 to SSII.
ChartMill assigns a fundamental rating of 1 / 10 to SSII. SSII has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months SSII reported a non-GAAP Earnings per Share(EPS) of -0.16. The EPS increased by 41.04% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -73.57% | ||
| ROE | -200.25% | ||
| Debt/Equity | 0.87 |